FCCC LOGO Faculty Publications
Martin VR
Cervical and endometrial cancers: an update
Developments in Supportive Cancer Care.. 1998 Mar;2(1) :3-10
PMID: 1998046580   
Back to previous list
Special Fields Contained : cited references. Special Interest Category: Oncologic Care Local Message: Locally Held: No Entry Week: 199808 Cited References: Landis SH, Murray T, Bolden S et al. Cancer statistics. CA Cancer J Clin 1998; 48: 3-48. Cited References: DiSaia PJ, Creasman WT. Clinical gynecologic oncology, 5th ed. St Louis, MO: Mosby Year Book; 1996. Cited References: Eigel PJ, Berek JS, Thigpen JT. Cancer of the cervix, vagina, and vulva. In: DeVita VT Jr., Hellman S, Rosenberg SA (eds), Cancer principles and practice of oncology, 5th ed. Philadelphia, PA: Lippincott-Raven; 1997: 1433-56. Cited References: Spinelli A. Preinvasive diseases of the cervix, vulva, and vagina. In: Moore GJ (ed), Women and cancer: a gynecology oncology nursing perspective. Boston, MA: Jones and Bartlett; 1997: 58-94. Cited References: Cannistra SA, Niloff JM. Cancer of the uterine cervix. N Engl J Med 1996: 1030-8. Cited References: Stehman FB, Perez CA, Kurman RJ et al. Uterine cervix. In: Hoskins WJ, Perez CA, Young RC (eds), Principles and practice of gynecology oncology, 2nd ed. Philadelphia, PA: JB Lippincott; 1997: 785-858. Cited References: Omura GA. Chemotherapy for cervix cancer. Semin Oncol 1994; 21: 54-62. Cited References: Park RC, Thigpen JT. Chemotherapy in advanced and recurrent cervical cancer, a review. Cancer 1993; 71: 1446-50. Cited References: Writing Group for the PEPI Trial. Effects of hormone replacement therapy on endometrial histology in postmenopausal women. JAMA 1996; 275: 370-5. Cited References: Jordan VC, Morrow M. Should clinicians be concerned about the carcinogenic potential of tamoxifen? Eur J Cancer 1994; 30: 1714-21. Cited References: Kurman RJ, Kaminski PF, Norris JH. The behavior of endometrial hyperplasia: a long term study of untreated hyperplasia in 170 patients. Cancer 1985; 56: 403-12. Cited References: Greven KM, Corn BW. Endometrial cancer. Curr Probl Cancer 1997; 21: 71-127. Cited References: Rose PG. Endometrial cancer. N Engl J Med 1996; 335: 640-9. Cited References: Aadlers J, Abeler V, Kostad P et al. Postoperative external irradiation and prognostic parameters in stage I endometrial cancer: clinical and histopathologic study of 540 patients. Obstet Gynecol 1980; 56: 419-27. Cited References: Vergote F, Kjorstadk K, Abeler V et al. A randomized trial of adjuvant progestin in early endometrial cancer. Cancer 1989; 64: 1011-6. Cited References: Moore TD, Phillips PH, Nerenstone SR et al. Systemic treatment of advanced and recurrent endometrial cancer: current status and future directions. J Clin Oncol 1991; 9: 1071-88. Cited References: Thigpen T, Blessing J, Homesley H et al. Phase III trial of doxorubicin +- cisplatin in advanced recurrent endometrial cancer: a GOG study. Proc Am Soc Clin Oncol 1993; 12: 261. abstract. Cited References: Ball HG, Blessing JA, Lentz SS et al. A phase II trial of Taxol in advanced and recurrent adenocarcinoma of the endometrium: a gynecologic oncology group study. Gynecol Oncol 1995; 56: 120. Cited References: Gossfeld LM, Cullen ML. Sexuality and fertility issues. In: Moore GJ (ed), Women and cancer: a gynecology oncology nursing perspective. Boston, MA: Jones and Bartlett; 1997: 540-57.